切换至 "中华医学电子期刊资源库"

中华肺部疾病杂志(电子版) ›› 2024, Vol. 17 ›› Issue (02) : 313 -315. doi: 10.3877/cma.j.issn.1674-6902.2024.02.032

短篇论著

AECOPD低钠血症发生风险及预测因素分析
周文欢1, 杨黎2,()   
  1. 1. 610081 成都,四川省建筑医院呼吸与危重症医学科
    2. 610500 成都,四川养老与老年健康协同创新中心;610500 成都,成都医学院第一附属医院呼吸与危重医学科
  • 收稿日期:2023-10-09 出版日期:2024-04-25
  • 通信作者: 杨黎
  • 基金资助:
    2022年度四川养老与老年健康协同创新中心联合(32)

Risk and predictors of hyponatremia in the acute exacerbation of chronic obstructive pulmonary disease

Wenhuan Zhou, Li Yang()   

  • Received:2023-10-09 Published:2024-04-25
  • Corresponding author: Li Yang
引用本文:

周文欢, 杨黎. AECOPD低钠血症发生风险及预测因素分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(02): 313-315.

Wenhuan Zhou, Li Yang. Risk and predictors of hyponatremia in the acute exacerbation of chronic obstructive pulmonary disease[J/OL]. Chinese Journal of Lung Diseases(Electronic Edition), 2024, 17(02): 313-315.

慢性阻塞性肺疾病急性加重期(acute exacerbation of chronic obstructive pulmonary disease, AECOPD)是慢性阻塞性肺疾病(chronic obstructive pulmonary disease, COPD)自然病程中的重要事件,对健康状况、住院率和疾病进展有不利影响[1,2,3,4]。代谢紊乱与AECOPD有关,以低钠血症常见[5]。低钠血症是人类有机体中常见的水电解质失衡,继发于神经系统疾病、消化系统疾病、心血管系统疾病等。社区获得性肺炎中低钠血症是复发的危险因素[6,7]。低钠血症引起的渗透压改变通过受体电位通道影响肺血管通透性,加重COPD,增加病死率。文献多报道低钠血症与COPD或AECOPD预后间的关系,对AECOPD低钠血症发生风险及预测因素报道尚少[8]。了解AECOPD低钠血症患病率和相关性因素,有助于提高认识和制定新的治疗策略。本文对我院收治的56例AECOPD患者低钠血症临床特征和预测因素进行分析,报道如下。

表1 AECOPD低钠血症发生风险单因素分析[(±s),n(%)]
表2 AECOPD低钠血症多因素Logistic回归分析
1
熊 锋,娄建丽. 慢性阻塞性肺疾病急性加重期预后的临床分析[J/CD]. 中华肺部疾病杂志(电子版), 2023, 16(4): 550-553.
2
Ritchie AI, Wedzicha JA. Definition, causes, pathogenesis, and consequences of chronic obstructive pulmonary disease exacerbations[J]. Clin Chest Med, 2020, 41(3): 421-438.
3
Sim YS, Lee JH, Lee EG, et al.COPD exacerbation-related pathogens and previous COPD treatment[J]. J Clin Med, 2022, 12(1): 111.
4
Jo YS, Han S, Lee D, et al. Development of a daily predictive model for the exacerbation of chronic obstructive pulmonary disease[J]. Sci Rep, 2023, 13(1): 18669.
5
Xiao M, Wang X, Wang H, et al. Risk factors for hyponatremia in acute exacerbation chronic obstructive pulmonary disease (AECOPD): a multicenter cross-sectional study[J]. BMC Pulm Med, 2023, 23(1): 39.
6
Potasso L, Sailer CO, Blum CA, et al. Mild to moderate hyponatremia at discharge is associated with increased risk of recurrence in patients with community-acquired pneumonia[J]. Eur J Intern Med, 2020, 75: 44-49.
7
Ni Y, Zhong H, Gu Y, et al. Clinical features, treatment, and outcome of psittacosis pneumonia: A multicenter study[J]. Open Forum Infect Dis, 2023, 10(2): 518.
8
García-Sanz MT, Martínez-Gestoso S, Calvo-Álvarez U, et al. Impact of hyponatremia on COPD exacerbation prognosis[J]. J Clin Med, 2020, 9(2): 503.
9
慢性阻塞性肺疾病急性加重(AECOPD)诊治专家组. 慢性阻塞性肺疾病急性加重(AECOPD)诊治中国专家共识(2017年更新版)[J]. 国际呼吸杂志2017, 37(14): 1041-1057.
10
张劭夫. 2014欧洲低钠血症诊疗临床实践指南解读[J]. 中国呼吸与危重监护杂志2015, 14(1): 103-106.
11
王 妍,闫 巍,柯 楠. 慢性阻塞性肺疾病前期特征、潜在诊断方法及干预策略[J]. 实用心脑肺血管病杂志2023, 31(10): 1-5.
12
Li S, Huang Q, Nan W, et al. Association between serum phosphate and in-hospital mortality of patients with AECOPD: A retrospective analysis on eICU database[J]. Heliyon, 2023, 9(9): e19748.
13
Pratt AJ, Purssell A, Zhang T, et al. Complexity in clinical diagnoses of acute exacerbation of chronic obstructive pulmonary disease[J]. BMC Pulm Med, 2023, 23(1): 298.
14
Bräunlich J, Turba K, Wirtz H. Reversibility of hypercapnia after an acute exacerbation of COPD[J]. Respiration, 2022, 101(9): 816-822.
15
Guecamburu M, Coquelin A, Rapin A, et al. Pulmonary rehabilitation after severe exacerbation of COPD: a nationwide population study[J]. Respir Res, 2023, 24(1): 102.
16
Tokgöz Akyıl F, Tural Önür S, Abalı H, et al. Hyponatremia is an independent predictor of emergency department revisits in acute exacerbation of COPD[J]. Clin Respir J, 2021, 15(10): 1063-1072.
17
王 淼,汪海娅. 老年住院患者低钠血症的临床特点[J]. 上海医药2023, 44(10): 27-30.
18
Lindner G, Herschmann S, Funk GC, et al. Sodium and potassium disorders in patients with COPD exacerbation presenting to the emergency department[J]. BMC Emerg Med, 2022, 22(1): 49.
19
张丽侠,王志芳,李 冲,等. 普通病房住院患者低钠血症及其性别、年龄特征的初步研究[J]. 临床内科杂志2018, 35(6): 412-414.
20
Ĉiauškaitē J, Gelžinienē G, Jurkevicienē G. Oxcarbazepine and hyponatremia[J]. Medicina (Kaunas), 2022, 58(5): 559.
21
Miyauchi T, Nishiwaki H, Mizukami A, et al. Hyponatremia and mortality in patients undergoing maintenance hemodialysis: Systematic review and meta-analysis[J]. Semin Dial, 2023, 36(4): 303-315.
22
吴琪茵,胡妙芬,黄雅萍,等. 探讨高血压对慢性阻塞性肺疾病急性加重患者发生低钠血症的影响[J]. 中外医疗2022, 41(28): 1-4.
23
Deep A, Behera PR, Subhankar S, et al. Serum electrolytes in patients presenting with acute exacerbation of chronic obstructive pulmonary disease (COPD) and their comparison with stable COPD patients[J]. Cureus, 2023, 15(4): e38080.
24
Che L, Song W, Zhang Y, et al. A randomized, double-blind clinical trial to evaluate the blood pressure lowing effect of low-sodium salt substitution on middle-aged and elderly hypertensive patients with different plasma renin concentrations[J]. J Clin Hypertens (Greenwich), 2022, 24(2): 140-147.
25
Sun Y, Wang H, Liang H, et al. A Method for estimating 24-hour urinary sodium excretion by casual urine specimen in Chinese hypertensive patients[J]. Am J Hypertens, 2021, 34(7): 718-728.
26
Knightly R, Milan SJ, Hughes R, et al. Inhaled magnesium sulfate in the treatment of acute asthma[J]. Cochrane Database Syst Rev, 2017, 11(11): CD003898.
27
Jahanian F, Khatir IG, Ahidashti HA, et al. The effect of intravenous magnesium sulphate as an adjuvant in the treatment of acute exacerbations of COPD in the emergency department: A double-blind randomized clinical trial[J]. Ethiop J Health Sci, 2021, 31(2): 267-274.
28
Pogozheva AV, Kodentsova VM, Sharafetdinov KK. [The role of magnesium and potassium in preventive and therapeutic nutrition][J]. Vopr Pitan, 2022, 91(5): 29-42.
29
Ni H, Aye SZ, Naing C. Magnesium sulfate for acute exacerbations of chronic obstructive pulmonary disease[J]. Cochrane Database Syst Rev, 2022, 5(5): CD013506.
[1] 黄鸿初, 黄美容, 温丽红. 血液系统恶性肿瘤患者化疗后粒细胞缺乏感染的危险因素和风险预测模型[J/OL]. 中华实验和临床感染病杂志(电子版), 2024, 18(05): 285-292.
[2] 陆婷, 陈浩, 王雪静, 谭若芸, 彭宇竹. 肾移植术后一年发生代谢综合征的危险因素分析[J/OL]. 中华移植杂志(电子版), 2024, 18(02): 98-103.
[3] 王石林, 叶继章, 丘向艳, 陈桂青, 邹晓敏. 慢性阻塞性肺疾病真菌感染风险早期预测分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 773-776.
[4] 方晓玉, 王婷, 赵珊, 陈锋. HALP指数对AECOPD并发呼吸衰竭患者ICU结局的预测意义[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(04): 639-641.
[5] 杨万荣, 任治坤, 时新颍. 沙丁胺醇雾化吸入脾多肽治疗AECOPD的疗效分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(04): 609-612.
[6] 程炜炜, 张青, 张诚实, 冯契靓, 陈荣荣, 赵云峰. 全身免疫炎症指数与慢性阻塞性肺疾病急性加重期病情严重程度相关性分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(04): 580-584.
[7] 陈杨, 李茜, 杨中华. 慢性阻塞性肺疾病急性加重期合并VTE抗凝治疗的研究进展[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(02): 316-319.
[8] 陈婷婷, 李春娟. 经鼻高流量湿化氧疗治疗AECOPD伴Ⅱ型呼吸衰竭的临床分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(02): 276-279.
[9] 周玲, 吴园明. 复方异丙托溴铵对AECOPD患者肺功能及血清IGF-Ⅱ、SOD水平的影响[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(01): 103-106.
[10] 董力, 李赫妍, 魏文斌. 人工智能在糖尿病视网膜病变中的应用进展[J/OL]. 中华眼科医学杂志(电子版), 2024, 14(01): 57-61.
[11] 蔡晓雯, 李慧景, 丘婕, 杨翼帆, 吴素贤, 林玉彤, 何秋娜. 肝癌患者肝动脉化疗栓塞术后疼痛风险预测模型的构建及验证[J/OL]. 中华临床医师杂志(电子版), 2024, 18(08): 722-728.
[12] 席静妮, 李娜, 张琪. 中性粒细胞与淋巴细胞比值对老年重症社区获得性肺炎进展为脓毒症的预测价值[J/OL]. 中华老年病研究电子杂志, 2024, 11(03): 28-31.
[13] 曹娟, 朱亚, 吴玉泉, 胡旭钢, 董芳, 洪逸莲, 桂莹. 改良Morse跌倒评估量表对老年住院患者跌倒风险的预测价值[J/OL]. 中华老年病研究电子杂志, 2024, 11(02): 1-4.
[14] 张宇, 王林. 急诊内科老年新型冠状病毒感染患者低钠血症发生情况调查分析[J/OL]. 中华老年病研究电子杂志, 2024, 11(02): 10-14.
[15] 解艳红, 陈凌燕, 邵晓露, 沈珊珊, 李方舟, 蓝肖燕. 老年住院患者衰弱风险预测模型研究进展[J/OL]. 中华老年病研究电子杂志, 2024, 11(01): 11-17.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?